Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Naarden Jacob Van currently holds 20,561.99 shares of Loxo Oncology, Inc. (LOXO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Naarden Jacob Van has been a net seller of LOXO stock. They have purchased $647.4K and sold $11.8M worth of shares.
Naarden Jacob Van's most recent insider trade was on Aug 13, 2025, when they purchased 1,000 shares at $647.36 per share.
Naarden Jacob Van serves as Executive at Loxo Oncology, Inc. (LOXO). They have executed 188 insider transactions totaling $12.4M over their tenure at the company.
Naarden Jacob Van holds the position of Executive at Loxo Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Naarden Jacob Van has shown a selling trading pattern, with $647.4K in total purchases and $11.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Naarden Jacob Van was on Feb 15, 2019, when they sold $4.5M worth of LOXO shares. This transaction involved 19,000 shares at $235.00 per share.
Naarden Jacob Van currently owns 20,561.99 shares of Loxo Oncology, Inc. (LOXO), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Naarden Jacob Van's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Naarden Jacob Van has 188 Form 4 filings on record as an insider at Loxo Oncology, Inc..
Set alerts for Naarden Jacob Van and 40,000+ other insiders.